Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2010 - 2026)

Integra Lifesciences Holdings has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.46 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 9.84% year-over-year to 0.46; the TTM figure through Jun 2026 stood at 0.46 (up 9.84% YoY), while the FY2025 annual figure was 0.43, up 3.93% from the prior year.
• Asset Utilization Ratio came in at 0.46 for Q2 2026 at Integra Lifesciences Holdings, up from 0.46 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.46 in Q2 2026 to a low of 0.38 in Q2 2024.
• Average Asset Utilization Ratio over 5 years is 0.42, with a median of 0.41 recorded in 2023.
• Year-over-year, Asset Utilization Ratio retreated 6.5% in 2024 and grew 16.84% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.4 in 2022, then advanced by 1.27% to 0.41 in 2023, then declined by 3.03% to 0.4 in 2024, then climbed by 13.51% to 0.45 in 2025, then grew by 2.27% to 0.46 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.46 in Q2 2026, 0.46 in Q1 2026, and 0.45 in Q4 2025.